ArticleAmerican journal of cancer research2021
Survival and prognosis analyses of concurrent PIK3CA mutations in EGFR mutant non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors.
Xiaotong Qiu et al.PubMed ↗Full text ↗
No numbers read from the abstract.
23 papers cite it
this papertrialcites it